Related Experiment Video
Updated: Jul 17, 2026
10:19
Substernal Thyroid Biopsy Using Endobronchial Ultrasound-guided Transbronchial Needle Aspiration
Published on: November 10, 2014
[Galectin-3 immunodetection in thyroid fine-needle aspirates: technical procedure and results]
Jean-François Collet1, Anne Fajac
1Cabinet de Cyto-Pathologie, 11 rue Cambronne, 75015 Paris. ajfcollet@wanadoo.fr
Annales De Pathologie
|January 27, 2007
Summary
Fine-needle aspiration cytology for thyroid nodules can be inconclusive for indeterminate lesions. Investigating Galectin-3 in these samples offers a potential method to improve diagnostic accuracy for thyroid cancer.
Area of Science:
- Endocrinology
- Oncology
- Cytopathology
Context:
- Fine-needle aspiration cytology (FNAC) is a primary diagnostic method for thyroid nodules.
- A significant proportion of FNAC results for thyroid nodules fall into the indeterminate category, complicating diagnosis.
- Distinguishing benign from malignant thyroid lesions based solely on cytology is challenging in indeterminate cases.
Purpose:
- To evaluate Galectin-3 as a molecular marker for thyroid malignancy in fine-needle aspiration samples.
- To present a simplified and easily implementable technical procedure for Galectin-3 assessment in FNAC specimens.
Summary:
- This study investigates the utility of Galectin-3, a known marker for thyroid malignancy, in fine-needle aspiration samples.
- The research focuses on indeterminate thyroid lesions where cytological findings are inconclusive.
- An accessible technical protocol for assessing Galectin-3 on FNAC samples is described.
Impact:
- Improved diagnostic accuracy for indeterminate thyroid nodules, potentially reducing unnecessary surgeries.
- Facilitating the clinical application of molecular markers in thyroid nodule evaluation.
- Enhancing the diagnostic yield of fine-needle aspiration cytology for thyroid cancer detection.
